Summary
This Global Burden of Disease Study 2023 synthesises epidemiological data on female breast cancer burden across 204 countries and territories from 1990 to 2023 using standardised GBD methodology, enabling temporal and geographical comparison of disease burden. The analysis extends projections to 2050 to inform cancer control policy and resource allocation globally. Data quality and surveillance coverage vary substantially by region, particularly in lower-income settings, which may limit the precision of regional estimates and future projections.
Regional applicability
This global study provides comparative context for the United Kingdom's breast cancer burden within international and regional frameworks, supporting evidence-based health policy and resource planning. UK data are incorporated into the GBD estimates, though the analysis focuses on global patterns and disparities rather than UK-specific policy application.
Key measures
Incidence rates, mortality rates, disability-adjusted life years (DALYs), age-standardised rates, regional and national estimates, temporal trends, projections to 2050
Outcomes reported
The study quantified incidence, mortality, and disability-adjusted life years (DALYs) attributable to female breast cancer across 204 countries and territories from 1990 to 2023, and extended projections to 2050 to inform cancer control policy and resource allocation.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.